Number of the records: 1  

Advanced NSCLC treated with gefitinib or erlotinib for five years or longer - updated data from the retrospective Slovakian study

  1. Info** Dokument nie je vo fonde knižnice **
    TitleAdvanced NSCLC treated with gefitinib or erlotinib for five years or longer - updated data from the retrospective Slovakian study
    Author infoPeter Beržinec, Peter Kasan, Juraj Mazal
    Co-authors Beržinec Peter
    Kasan Peter
    Mazal Juraj
    NotePopis urobený z citácie
    Source Abstract IASLC 2019 World Conference on Lung Cancer, 2019
    LanguageEnglish
    Document kindRozpis článkov zo zborníkov
    DatabaseARTICLES
    article

    article

Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.

Accept allSettingsReject all